Digestive & Intestinal Remedies (Pharmacies) - Germany

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$631.60m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.29%, resulting in a market volume of US$673.30m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$7.59 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Germany is experiencing steady growth and development. Customer preferences in the market are driven by the increasing awareness of digestive health and the desire for natural remedies. Consumers are becoming more conscious of their overall well-being and are seeking products that can alleviate common digestive issues such as indigestion, bloating, and heartburn. This has led to a growing demand for digestive and intestinal remedies that are gentle on the stomach and made from natural ingredients. Trends in the market include the rise of probiotics and herbal remedies. Probiotics, which are beneficial bacteria that promote healthy digestion, have gained popularity among consumers seeking natural solutions for their digestive problems. Additionally, herbal remedies such as peppermint oil and ginger extract are being used to soothe digestive discomfort. These trends reflect a shift towards holistic approaches to digestive health and a preference for natural remedies over traditional pharmaceutical options. Local special circumstances in Germany also contribute to the development of the Digestive & Intestinal Remedies market. Germany has a strong tradition of herbal medicine and natural remedies, with a significant portion of the population relying on alternative therapies for their health needs. This cultural preference for natural remedies has influenced the demand for digestive and intestinal remedies in the country. Furthermore, Germany has a well-established healthcare system with a high level of access to pharmacies, making it easy for consumers to purchase these products. Underlying macroeconomic factors play a role in the growth of the market as well. Germany has a stable economy with a high standard of living, which allows consumers to prioritize their health and well-being. Additionally, the aging population in Germany is driving the demand for digestive and intestinal remedies, as older individuals are more prone to digestive issues. The increasing prevalence of sedentary lifestyles and unhealthy eating habits also contribute to the demand for these products. Overall, the Digestive & Intestinal Remedies (Pharmacies) market in Germany is experiencing growth due to customer preferences for natural remedies, trends towards holistic approaches to digestive health, local cultural preferences, and underlying macroeconomic factors. As the market continues to develop, it is likely that there will be a greater emphasis on natural and herbal remedies, as well as an increased focus on preventive measures for digestive health.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.